Skip to main content
Clinical Trials/RBR-8jcwjp
RBR-8jcwjp
Recruiting
未知

Prospective randomized, double-blind, placebo-controlled study of the effects of the Transcranial Led Therapy Intervention (TLT) on anxiety and depression in patients with traumatic brain injury (TBI).

Centro Universitário UniFacid0 sitesJune 25, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Craniocerebral Trauma, anxiety, depression, Pathological conditions, signs and symptoms, Low-Level Light Therapy
Sponsor
Centro Universitário UniFacid
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 25, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Centro Universitário UniFacid

Eligibility Criteria

Inclusion Criteria

  • subject between 18 and 60 years old; ability to understand and follow instructions in Portuguese; Glasgow Coma Scale of entry equal to or greater than 12; TBI time from 3 months.

Exclusion Criteria

  • subjects under 18 or over 60; limiting language and / or motor impairment; non\-signature of the informed consent form, presence of important bone defects in the regions of the skull to be stimulated, presence of epilepsy after uncontrolled TBI.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Antioxidant therapy in implementing lithotripsy in patients with renal lithiasisKidney stone disease treated by extracorporeal shockwave lithotripsyUrological and Genital DiseasesCalculus of kidney and ureter
ISRCTN98702137Reina Sofia Universitary Hospital (Spain)126
Active, not recruiting
Not Applicable
Prospective, randomized, doubleblind, placebo-controlled trial on changes in acetylcholine receptor antibody titres in autoimmune myasthenia gravis after influenza vaccination (ProPATIent) - ProPATIentGeneralized Myasthenia gravis with positive antibodies against Acetylcholine-receptors (ICD10GM2006 G70.0)
EUCTR2006-004374-27-DEPhilipps-University
Active, not recruiting
Not Applicable
Prospective, randomized, double blind placebo-controlled trial on the efficacy of growth hormone replacement therapy in adult patients with isolated growth hormone deficiency (PRO ISO-GHD Study) - PRO ISO-GHD StudyIsolated Adult Growth Hormone DeficiencyMedDRA version: 9.1Level: LLTClassification code 10056438Term: Growth hormone deficiency
EUCTR2007-000790-36-DEPfizer Pharma GmbH50
Completed
Phase 1
Meperidine versus valethamate bromide in shortening the duration of laborShortening the duration of laborReproductive Health and Childbirth - Childbirth and postnatal careReproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12609000153213Dr Sefa Kelekci39
Active, not recruiting
Phase 1
Prospective, double-blind, randomised, placebo controlled, phase III clinical study assessing the efficacy of natural progesterone 25 mg/bid administered subcutaneously in the maintenance of early pregnancy in women with symptoms of threatened abortion.
EUCTR2016-002777-35-ITIBSA INSTITUT BIOCHIMIQUE SA268